2022

Circulogene Convertible Note – June 2022

Aquestive Capital Markets Advisory – April 2022

Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock

X4 Pharmaceuticals Prices $65.0 Million Public Offering

CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price

AGBA ACQUISITION LIMITED COMPLETES BUSINESS COMBINATION WITH TAG HOLDINGS LIMITED

Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split

Outlook